Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels [4]

Thrombosis and Haemostasis

Volumn 93, Issue 2, 2005, Pages 392-393

  Franchini, Massimo ^a   Veneri, Dino ^b   Lippi, Giuseppe ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; LEVOTHYROXINE; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE; VON WILLEBRAND FACTOR;

BLEEDING; BLOOD CLOTTING TEST; BLOOD GROUP TYPING; BLOOD SAMPLING; DRUG HALF LIFE; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LETTER; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; THROMBOEMBOLISM; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

EID: 13844275670     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616250     Document Type: Letter

References (6)

1. Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 1965; 273: 1057-61.
2. Myrup B, Bregengård C, Faber J. Primary haemostasis and thyroid disease. J Int Med 1995; 238: 59-63.
3. Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997; 136: 1-7.
4. Michiels JJ, Budde U, van der Planken, van Vliet HHDM, Schoyens W, Berneman Z. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol 2001; 14: 401-36.
5. Franchini M, de Gironcoli M, Lippi G, et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haemophilia 2002; 8: 142-4.
6. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38.